Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity?

被引：12

作者：

Jain, Preetesh ^{[1
]}

Ok, Chi Young ^{[1
]}

Konoplev, Sergej ^{[1
]}

Patel, Keyur P. ^{[1
]}

Jorgensen, Jeffrey ^{[1
]}

Estrov, Zeev ^{[1
]}

Luthra, Raja ^{[1
]}

Kantarjian, Hagop ^{[1
]}

Ravandi, Farhad ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 07期

关键词：

MUTATIONS; V600E; ASSAY;

D O I：

10.1200/JCO.2013.50.9661

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E57 / E60

页数：4

共 36 条

[21] High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias
Waterfall, Joshua J.
Arons, Evgeny
Walker, Robert L.
Pineda, Marbin
Roth, Laura
Killian, J. Keith
Abaan, Ogan D.
Davis, Sean R.
Kreitman, Robert J.
Meltzer, Paul S.
NATURE GENETICS, 2014, 46 (01) : 8 - +
[22] High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias
Joshua J Waterfall
Evgeny Arons
Robert L Walker
Marbin Pineda
Laura Roth
J Keith Killian
Ogan D Abaan
Sean R Davis
Robert J Kreitman
Paul S Meltzer
Nature Genetics, 2014, 46 : 8 - 10
[23] CD5-negative, CD10-negative small B-cell leukemia: Variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh, SS
Kallakury, BVS
Al-Kuraya, KA
Meck, J
Hartmann, DP
Bagg, A
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (04) : 306 - 310
[24] VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy
Arons, Evgeny
Suntum, Tara
Stetler-Stevenson, Maryalice
Kreitman, Robert J.
BLOOD, 2009, 114 (21) : 4687 - 4695
[25] Antigenic variation of hairy cell leukemia defines a CD25 negative variant with a uniform immunophenotype and distinct clinicopathologic features
Dong, HY
BLOOD, 2004, 104 (11) : 313A - 313A
[26] Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial
Tiacci, Enrico
De Carolis, Luca
Zinzani, Pier Luigi
Pulsoni, Alessandro
Zaja, Francesco
Cimminiello, Michele
Ambrosetti, Achille
Rossi, Davide
Motta, Giovanna
Varettoni, Marzia
Fraticelli, Vincenzo
Carella, Angelo Michele
Anastasia, Antonella
Leoni, Pietro
Rambaldi, Alessandro
Pileri, Stefano Aldo
Foa, Robin
Falini, Brunangelo
BLOOD, 2014, 124 (21)
[27] Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
Marincevic, Millaray
Mansouri, Mahmoud
Kanduri, Meena
Isaksson, Anders
Goransson, Hanna
Smedby, Karin Ekstrom
Jurlander, Jesper
Juliusson, Gunnar
Davi, Fred
Stamatopoulos, Kostas
Rosenquist, Richard
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (12): : 2072 - 2079
[28] Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant A case report
Imoto, Naoto
Koyama, Daisuke
Sugiura, Isamu
Kurahashi, Shingo
MEDICINE, 2021, 100 (05) : E24457
[29] THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL
Tiacci, E.
De Carolis, L.
Broccoli, A.
Pulsoni, A.
Mazzucco, M.
Cimminiello, M.
Ambrosetti, A.
Rossi, D.
Motta, G.
Varettoni, M.
Fraticelli, V.
Carella, A. M.
Anastasia, A.
Leoni, P.
Rambaldi, A.
Falzetti, F.
Ascani, S.
Capponi, M.
Martelli, M. P.
Pileri, S. A.
Foa, R.
Zinzani, P. L.
Falini, B.
HAEMATOLOGICA, 2015, 100 : 1 - 2
[30] Somatic hypermutations in hairy cell leukemia suggest a canonical process, except in patients with the poor-prognosis VH4-34 variant
Arons, Eugeny
Suntun, Tara
Kreitman, Robert J.
CANCER RESEARCH, 2010, 70

← 1 2 3 4 →